ANYO’ Aesthetics offers a medically supervised weight management program utilizing GLP-1 receptor agonist therapy designed to support safe, effective, and sustainable fat loss. GLP-1 medications are a modern, evidence-based approach to weight management that work by regulating appetite, improving satiety, and helping patients reduce overall caloric intake without extreme dieting or unsafe stimulant use.
Tirzepatide (GLP-1/GIP)
ANYO’ Aesthetics offers a medically supervised weight management program using tirzepatide therapy, a next-generation treatment designed to support significant, sustainable fat loss and metabolic improvement. Tirzepatide is a dual GIP and GLP-1 receptor agonist that helps regulate appetite, enhance satiety, improve insulin sensitivity, and reduce cravings—making it a powerful option for patients struggling with stubborn weight gain or weight loss resistance.
Semaglutide (GLP-1)
ANYO’ Aesthetics offers a medically supervised semaglutide weight management program designed to support safe, consistent, and sustainable fat loss. Semaglutide is a GLP-1 receptor agonist that works by reducing appetite, increasing feelings of fullness, and helping regulate blood sugar levels—making it an effective option for patients struggling with stubborn weight gain or difficulty losing weight through diet and exercise alone.